AbbVie
ABBV
#31
Rank
HK$2.356 T
Marketcap
HK$1,334
Share price
-1.51%
Change (1 day)
5.61%
Change (1 year)

The biotechnology and pharmaceutical company Abbvie, spelled AbbVie, was founded in 2013 as a spin-off from Abbott Laboratories and is traded on the NYSE stock exchange in the S&P 100 index under the symbol โ€œABBVโ€.

AbbVie (ABBV) - Total liabilities

Total liabilities on the balance sheet as of September 2024 : HK$1.069 Trillion

According to AbbVie's latest financial reports the company's total liabilities are HK$1.069 Trillion. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

AbbVie - Total liabilities on balance sheet (from 2011 to 2024)

Total liabilities by year

Year Total liabilities Change
2023-12-31HK$970.89 B2.26%
2022-12-31HK$949.45 B-7.12%
2021-12-31HK$1.022 T-4.08%
2020-12-31HK$1.065 T40.65%
2019-12-31HK$757.68 B42.71%
2018-12-31HK$530.91 B3.45%
2017-12-31HK$513.22 B7.68%
2016-12-31HK$476.61 B25.23%
2015-12-31HK$380.59 B90.4%
2014-12-31HK$199.89 B4.34%
2013-12-31HK$191.57 B4.53%
2012-12-31HK$183.27 B210.94%
2011-12-31HK$58.94 B39.44%
2010-12-31HK$42.27 B

Total liabilities for similar companies or competitors

Company Total liabilities differencediff. Country
HK$988.10 B-7.60%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$595.35 B-44.33%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$477.13 B-55.38%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$648.96 B-39.31%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$281.32 B-73.69%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$93.06 B-91.30%๐Ÿ‡บ๐Ÿ‡ธ USA
HK$464.66 B-56.55%๐Ÿ‡ฌ๐Ÿ‡ง UK
HK$499.17 B-53.32%๐Ÿ‡ฌ๐Ÿ‡ง UK
HK$6.35 B-99.41%๐Ÿ‡บ๐Ÿ‡ธ USA